+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Vaccine Adjuvants Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Vaccine Adjuvants Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
NK Cell Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

NK Cell Therapies - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
From
Hepatitis B Vaccines Market 2020-2024 - Product Thumbnail Image

Hepatitis B Vaccines Market 2020-2024

  • Report
  • October 2020
  • 120 Pages
  • Global
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 194 Pages
  • Global
From
Recombinant Vaccines Market Report and Forecast 2023-2031 - Product Thumbnail Image

Recombinant Vaccines Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Loading Indicator